Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersOperating IncomePreferred Dividend PaymentsProfit After TaxRevenueShares Outstanding (Weighted Average)
Others
Ratios

cbdMD (YCBD) Cost of Revenue (2016 - 2025)

Historic Cost of Revenue for cbdMD (YCBD) over the last 10 years, with Q3 2025 value amounting to $1.9 million.

  • cbdMD's Cost of Revenue fell 756.17% to $1.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was $7.2 million, marking a year-over-year decrease of 353.18%. This contributed to the annual value of $7.2 million for FY2025, which is 353.18% down from last year.
  • cbdMD's Cost of Revenue amounted to $1.9 million in Q3 2025, which was down 756.17% from $1.8 million recorded in Q2 2025.
  • cbdMD's 5-year Cost of Revenue high stood at $4.3 million for Q4 2021, and its period low was $1.7 million during Q4 2024.
  • Moreover, its 5-year median value for Cost of Revenue was $2.2 million (2023), whereas its average is $2.5 million.
  • As far as peak fluctuations go, cbdMD's Cost of Revenue surged by 3334.65% in 2021, and later crashed by 4183.75% in 2022.
  • cbdMD's Cost of Revenue (Quarter) stood at $4.3 million in 2021, then crashed by 41.84% to $2.5 million in 2022, then decreased by 27.79% to $1.8 million in 2023, then fell by 5.78% to $1.7 million in 2024, then rose by 13.47% to $1.9 million in 2025.
  • Its Cost of Revenue was $1.9 million in Q3 2025, compared to $1.8 million in Q2 2025 and $1.8 million in Q1 2025.